Streetbeat News

Products Services

CGC

CURLF

PCLOF

TLRY

The Czech Republic could miss out on $242 million annually by not regulating its marijuana market, according to a study. The study suggests that a comprehensive model, including self-cultivation, cannabis clubs, and a commercial market, would yield the highest social benefits. Companies like Curaleaf, PharmaCielo, Tilray, and Canopy Growth are already expanding their presence in the Czech market, potentially benefiting from future policy changes.

Portfolio Pulse from Jelena Martinovic

September 16, 2024 | 2:00 pm

AIPI

AMZN

CRWD

LRNZ

NVDA

CrowdStrike, Amazon, and NVIDIA have launched the second annual Cybersecurity Startup Accelerator to support AI and cloud security startups. The program offers funding, technical expertise, and market opportunities. CrowdStrike shares rose 2.04% following the announcement.

Portfolio Pulse from Lekha Gupta

September 16, 2024 | 1:59 pm

LQDA

UTHR

A court ruling found that United Therapeutics' interference with the launch of a generic Treprostinil Injection caused over $137M in losses. Liquidia Corporation, in partnership with Sandoz, was affected by this interference.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 1:43 pm

VRNT

Verint Systems showcases the success of its AI-powered bots in enhancing sales and customer interactions for various clients, including an automotive retailer and financial institutions. The deployment of Verint's bots has led to significant improvements in upsell rates and sales growth.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 1:43 pm

PBM

Psyence Biomedical, a NASDAQ-listed associate of Psyence Group, has initiated its first trial site in Australia for a Phase IIb study. The study focuses on using nature-derived psilocybin as a potential treatment for adjustment disorder in palliative care.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 1:36 pm

MSTR

Canaccord Genuity has lowered its price target for MicroStrategy (MSTR) from $185 to $173, while maintaining a Buy rating. The adjustment is due to MicroStrategy's aggressive Bitcoin acquisition strategy, with over $1.1 billion in Bitcoin purchased recently. Despite the lower target, Canaccord remains optimistic about MicroStrategy's strategy and the Bitcoin market.

Portfolio Pulse from Murtuza Merchant

September 16, 2024 | 1:33 pm

META

Meta Platforms Inc is using UK Facebook and Instagram posts for AI training, defying EU privacy laws. Privacy groups criticize this move, and the ICO will monitor compliance. Meta's stock faces resistance at $540, with investors watching for a breakthrough.

Portfolio Pulse from Zaheer Anwari

September 16, 2024 | 1:31 pm

MRK

NCNA

NuCana's stock surged after presenting positive Phase 2 study results for its melanoma treatment, NUC-7738, in combination with Merck's Keytruda. The study showed promising disease control and progression-free survival in patients resistant to PD-1 inhibitors.

Portfolio Pulse from Vandana Singh

September 16, 2024 | 1:28 pm

NTRA

Natera's stock is rising following the publication of three new peer-reviewed papers, adding to a total of over 85 publications on its cancer diagnostic test, Signatera.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 1:22 pm

ASND

Ascendis Pharma's shares rose following the announcement of positive topline data from its pivotal trial of Transcon CNP (Navepegritide).

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 1:17 pm